992 related articles for article (PubMed ID: 12847818)
1. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
2. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
Szapary L; Horvath B; Marton Z; Alexy T; Demeter N; Szots M; Klabuzai A; Kesmarky G; Juricskay I; Gaal V; Czopf J; Toth K
Clin Hemorheol Microcirc; 2004; 31(1):1-9. PubMed ID: 15272148
[TBL] [Abstract][Full Text] [Related]
3. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
4. [Hemorheologic factors in hypertensive and diabetic retinopathy].
Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B
Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065
[TBL] [Abstract][Full Text] [Related]
5. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in hemorheological parameters of coronary artery disease patients.
Bogar L; Juricskay I; Kesmarky G; Feher G; Kenyeres P; Toth K
Clin Hemorheol Microcirc; 2006; 35(1-2):99-103. PubMed ID: 16899912
[TBL] [Abstract][Full Text] [Related]
7. Hemorheological parameters and aging.
Feher G; Koltai K; Kesmarky G; Szapary L; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2006; 35(1-2):89-98. PubMed ID: 16899911
[TBL] [Abstract][Full Text] [Related]
8. Hemorheological alterations in patients with diabetic retinopathy.
Vekasi J; Marton ZS; Kesmarky G; Cser A; Russai R; Horvath B
Clin Hemorheol Microcirc; 2001; 24(1):59-64. PubMed ID: 11345235
[TBL] [Abstract][Full Text] [Related]
9. Hemorheological background of acetylsalicylic acid resistance.
Feher G; Koltai K; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
[TBL] [Abstract][Full Text] [Related]
10. Hemorheological disturbances in cerebrovascular diseases.
Velcheva I; Antonova N; Titianova E; Damianov P; Dimitrov N; Dimitrova V
Clin Hemorheol Microcirc; 2008; 39(1-4):391-6. PubMed ID: 18503150
[TBL] [Abstract][Full Text] [Related]
11. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
[TBL] [Abstract][Full Text] [Related]
12. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
13. Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study.
Koscielny J; Jung EM; Mrowietz C; Kiesewetter H; Latza R
Clin Hemorheol Microcirc; 2004; 31(3):185-95. PubMed ID: 15322324
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipids and blood viscosity in patients with cerebrovascular disease.
Velcheva I; Antonova N; Dimitrova V; Dimitrov N; Ivanov I
Clin Hemorheol Microcirc; 2006; 35(1-2):155-7. PubMed ID: 16899921
[TBL] [Abstract][Full Text] [Related]
15. Comparative values of erythrocyte aggregability versus other indices of hemorheological disorders in patients with ischemic brain infarcts.
Mchedlishvili G; Shakarishvili R; Momtselidze N; Gobejishvili L; Aloeva M; Mantskava M
Clin Hemorheol Microcirc; 2000; 22(1):9-15. PubMed ID: 10711816
[TBL] [Abstract][Full Text] [Related]
16. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
Vekasi J; Koltai K; Gaal V; Toth A; Juricskay I; Kesmarky G
Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
[TBL] [Abstract][Full Text] [Related]
17. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
Marotta F; Safran P; Tajiri H; Princess G; Anzulovic H; Idéo GM; Rouge A; Seal MG; Idéo G
Hepatogastroenterology; 2001; 48(38):511-7. PubMed ID: 11379344
[TBL] [Abstract][Full Text] [Related]
18. [Hemorheological alterations in hypertensive patients].
Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
[TBL] [Abstract][Full Text] [Related]
19. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
